Pharma, biopharma, and medical device makers should watch out for these perennial problems, which include inadequate ...

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company (“PHAXIAM” or “the Company”) developing innovative ...

Hyderabad: Granules India Limited has announced that the Company's Unit V facility located at Anakapally, Visakhapatnam, ...

Leading UK contract development and manufacturing organisation (CDMO) Upperton Pharma Solutions, has completed the build of ...

News were allowed into the Gold and Silver Command Rooms for the very first time to oversee the operation for Manchester ...

The medical cannabis product is launched under the brand IndiMed and manufactured at Aurora's EU-GMP facility in Leuna, Germany.

Imexpharm Corporation reported VND2,205 billion (US$87.3 million) in net revenue for 2024, marking a 10.6% year-on-year increase.

Aurora Cannabis (TSX:ACB), a global cannabis stock, is releasing its first German-cultivated dried flower product under the IndiMed brand on January 27 ・The strain, Island Sweet Skunk, is a ...

Announces today the launch of the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading EU-GMP facility in Leuna, Germany, the new brand ...

Aurora Cannabis (ACB) announces the launch of the company’s first German-cultivated medical cannabis product, under the brand IndiMed.

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, ...

Venus Remedies has secured the renewal of its EU-GMP certification from Infarmed, Portugal, for its Cephalosporin, Carbapenem ...